Developer docs
API playgroundTry for free, no card

Search company profiles

Bonerge Lifescience

Full company profile

uuid006fcpm

Namestring
Bonerge Lifescience
Legal namestring
Bonerge Lifescience
Websiteurl
bonerge.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives for global supplement, functional food, and cosmetic brand customers. The company's portfolio spans seven core branded ingredients (BeFisetin fisetin, EquoYouth S-Equol, StanYouth Urolithin A, GlucoSober dihydroberberine, Amuctive Akkermansia muciniphila, MitoSober PQQ, and QinMito L-Ergothioneine), a cosmeceutical line for topical beauty-from-within applications, a set of classic polyphenol ingredients, and synergistic formulations such as StanYouth CR3. Underlying these products are three proprietary delivery platforms (Oil-Soluble emulsification, Water-Soluble liposomal systems, and a High-Bioavailability Softgel platform) that claim multi-fold bioavailability improvements versus conventional forms.

Revenue is generated through one-time ingredient sales to B2B customers combined with ODM and CDMO service engagements that bundle formulation development, scale-up, and clinical trial expertise for brand partners. Go-to-market is enterprise field sales supplemented by content marketing, scientific conference presentations, and trade show presence at SupplySide Global/East/West, Natural Products Expo West, and Vitafoods Europe. Key customer segments are women's health supplement brands, longevity and anti-aging manufacturers, metabolic health companies (including GLP-1 companion nutrition), and beauty/cosmetics brands, with ODM/CDMO clients representing an additional business unit.

The company is headquartered at Zhongjian Smart Valley, Yuelu District, Changsha, Hunan Province, China, with U.S. sales contact infrastructure, and identifies 11-50 employees. It has achieved recent regulatory and clinical milestones including Self-Affirmed GRAS status for BeFisetin (April 2025) and EquoYouth S-Equol (December 2025), a 108-participant senolytic clinical trial for skin rejuvenation, a published collaboration with Mayo Clinic on IL-23R as an anti-aging biomarker, and recognition from the China Astronaut Scientific Research and Training Center for circadian rhythm research on StanYouth.

Short descriptiontext

Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives (including fisetin, urolithin A, S-equol, and dihydroberberine) for global supplement and cosmetic brand manufacturers, supported by ODM and CDMO services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChangsha, China
HQ citystring
Changsha
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nutraceutical ingredient manufacturing, cosmeceutical active ingredients, branded dietary supplement ingredients, ODM CDMO services, longevity health ingredients
Industry3 codes
PRIMARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYCRADAGAI
Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Nutraceutical Ingredients
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Branded Ingredient Sales
TypeOne Time License
Description

Sale of proprietary branded nutraceutical ingredients including BeFisetin Fisetin, StanYouth Urolithin A, EquoYouth S-Equol, Dihydroberberine, Amuctive Akkermansia, MitoSober PQQ, QinMito L-Ergothioneine. B2B supplier model to supplement and cosmetic manufacturers.

bonerge.com
2Cosmeceutical Ingredient Sales
TypeOne Time License
Description

Sale of bioactive ingredients for topical cosmetic applications including Fisetin Cosmetic, Urolithin A Cosmetic, L-Ergothionine Cosmetic.

bonerge.com
3ODM Services
TypeProfessional Services
Description

End-to-end formulation and manufacturing support including competitor analysis, consumer research, formula development, sampling, testing, optimization, and commercial-scale production.

bonerge.com
4CDMO Services
TypeProfessional Services
Description

Contract development and manufacturing services for patented active ingredients, exclusive formulations, novel delivery systems, and clinical trial expertise.

bonerge.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1BeFisetin®
Description

Premium branded fisetin ingredient - the first and only SA-GRAS certified fisetin with >99% purity.

bonerge.com
+7 more records
Core offering1 text field

Bonerge Lifescience is a B2B ingredient manufacturer that develops, produces, and supplies nutraceutical and cosmeceutical raw materials to dietary supplement and personal care brands. The portfolio spans branded, clinically-supported longevity actives (such as fisetin, urolithin A, S-equol, L-ergothioneine, and PQQ) plus classic polyphenolic ingredients (apigenin, luteolin, resveratrol, polydatin, mangiferin, spermidine), delivered through proprietary bioavailability platforms. The company also offers ODM and CDMO services for finished dietary supplement products, including custom formulation, softgel encapsulation, and full turnkey brand support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 54x higher bioavailability compared to berberine for dihydroberberine
+4 more records
Product overview1 text field

Bonerge Lifescience is an innovative manufacturer providing comprehensive turn-key solutions in the nutraceutical and cosmeceutical ingredients industries. The company operates a multi-tiered product portfolio consisting of: (1) Branded Ingredients including EquoYouth™ S-Equol, StanYouth® Urolithin A, BeFisetin® Fisetin, Dihydroberberine (GlucoSober™), Amuctive™ Akkermansia, MitoSober® PQQ, and QinMito® L-Ergothioneine; (2) Cosmeceutical Ingredients for beauty-from-within applications; (3) Classic Ingredients including Apigenin, Luteolin, Genistein, Polydatin, Resveratrol, Mangiferin, and Spermidine; (4) Synergistic Formulations such as StanYouth® CR3; (5) ODM & CDMO manufacturing services; and (6) Proprietary Technology Platforms (Oil Soluble, Water Soluble, High-Bioavailability Softgel) that enhance bioavailability of active ingredients. The company focuses on ingredients for Ageless Energy, Healthspan, and Longevity.

Product and service1 record
1EquoYouth™ S-Equol
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1NUS Centre for Healthy Longevity
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Conference sponsor and participant at CHL Scientific Conference focused on healthy longevity supplements. Engaged with leading longevity researchers including Dr. Brian Kennedy, Dr. David Sinclair, Dr. Guido Kroemer, and Dr. Laura Niedernhofer to explore senolytic mechanisms and mitophagy research.

bonerge.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based specialty ingredient supplier focused on branded, science-backed nutraceutical ingredients for healthy aging, cognitive, and metabolic health. Highly comparable mid-size competitor in Bonerge's target categories with established North American distribution.

TypeDirect peer
Description

Pioneer of branded, clinically-validated urolithin A ingredient (Mitopure) targeting mitochondrial health and longevity. Directly overlaps Bonerge's StanYouth® Urolithin A in active ingredient, indication (longevity), and B2B ingredient-supply model.

TypeBroad incumbent
Description

Major Japanese fermentation-based ingredient manufacturer (e.g., Cognizin citicoline, branded amino acids) supplying global nutraceutical brands. Comparable as a fermentation-purity-focused, branded-ingredient supplier and a credible competitor in longevity and metabolic actives.

TypeDirect peer
Description

Globally recognized manufacturer of standardized nutraceutical ingredients (curcuminoids, bioactives) with branded SKUs, clinical backing, and a global B2B sales network. Closely comparable to Bonerge's model of branded, clinically-supported nutraceutical ingredients sold to supplement brands.

TypeDirect peer
Description

Specialty nutraceutical ingredient distributor sourcing and marketing branded ingredients (many from Asia) to US supplement brands. Comparable business model to Bonerge's B2B branded-ingredient sales, particularly for the women's health and longevity categories.

6ChromaDex
TypeDirect peer
Description

Public ingredient company behind Niagen® (nicotinamide riboside) and Tru Niagen, with strong IP and clinical evidence in the NAD+/longevity category. Highly comparable as a science-driven, branded-ingredient supplier in the longevity supplement market.

7BioActor
TypeEmerging player
Description

Dutch developer and supplier of proprietary branded nutraceutical ingredients for metabolic, bone, and muscle health. Comparable as a smaller European science-driven ingredient supplier overlapping Bonerge's metabolic and women's health segments.

TypeDirect peer
Description

Vertically integrated nutraceutical ingredient manufacturer with branded ingredients (e.g., BioPerine, Saberry) sold globally to supplement brands. Comparable B2B model with branded, clinically backed ingredients spanning metabolic, anti-aging, and women's health.

9Lonza Capsules & Health Ingredients
TypeBroad incumbent
Description

Global CDMO and ingredient manufacturer offering delivery technologies (lipid multiparticulates, softgels) and bioavailability-enhanced ingredients to nutraceutical and pharma customers. Competes with Bonerge's delivery platforms and CDMO service lines at a much larger scale.

TypeEmerging player
Description

Specialty ingredient company focused on branded, clinically-validated longevity and metabolic health actives (e.g., PeptiStrong). Similar size and positioning as Bonerge — emerging branded-ingredient supplier targeting the same healthspan supplement market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bonerge Lifescience

Nutraceutical Ingredientsbonerge.com

Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives (including fisetin, urolithin A, S-equol, and dihydroberberine) for global supplement and cosmetic brand manufacturers, supported by ODM and CDMO services.

What Bonerge Lifescience does

Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives for global supplement, functional food, and cosmetic brand customers. The company's portfolio spans seven core branded ingredients (BeFisetin fisetin, EquoYouth S-Equol, StanYouth Urolithin A, GlucoSober dihydroberberine, Amuctive Akkermansia muciniphila, MitoSober PQQ, and QinMito L-Ergothioneine), a cosmeceutical line for topical beauty-from-within applications, a set of classic polyphenol ingredients, and synergistic formulations such as StanYouth CR3. Underlying these products are three proprietary delivery platforms (Oil-Soluble emulsification, Water-Soluble liposomal systems, and a High-Bioavailability Softgel platform) that claim multi-fold bioavailability improvements versus conventional forms.

Revenue is generated through one-time ingredient sales to B2B customers combined with ODM and CDMO service engagements that bundle formulation development, scale-up, and clinical trial expertise for brand partners. Go-to-market is enterprise field sales supplemented by content marketing, scientific conference presentations, and trade show presence at SupplySide Global/East/West, Natural Products Expo West, and Vitafoods Europe. Key customer segments are women's health supplement brands, longevity and anti-aging manufacturers, metabolic health companies (including GLP-1 companion nutrition), and beauty/cosmetics brands, with ODM/CDMO clients representing an additional business unit.

The company is headquartered at Zhongjian Smart Valley, Yuelu District, Changsha, Hunan Province, China, with U.S. sales contact infrastructure, and identifies 11-50 employees. It has achieved recent regulatory and clinical milestones including Self-Affirmed GRAS status for BeFisetin (April 2025) and EquoYouth S-Equol (December 2025), a 108-participant senolytic clinical trial for skin rejuvenation, a published collaboration with Mayo Clinic on IL-23R as an anti-aging biomarker, and recognition from the China Astronaut Scientific Research and Training Center for circadian rhythm research on StanYouth.

Bonerge Lifescience firmographics

Firmographics
Name
Bonerge Lifescience
Legal name
Bonerge Lifescience
Website
https://bonerge.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives (including fisetin, urolithin A, S-equol, and dihydroberberine) for global supplement and cosmetic brand manufacturers, supported by ODM and CDMO services.
Ownership category
akta.pro rank

Bonerge Lifescience industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYCRADAGAI
Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Nutraceutical ingredient manufacturing
  • Cosmeceutical active ingredients
  • Branded dietary supplement ingredients
  • ODM CDMO services
  • Longevity health ingredients

Where Bonerge Lifescience is headquartered

Location

Headquarters

HQ city
Changsha
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Bonerge Lifescience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales

Revenue model

  1. Branded Ingredient Sales: Sale of proprietary branded nutraceutical ingredients including BeFisetin Fisetin, StanYouth Urolithin A, EquoYouth S-Equol, Dihydroberberine, Amuctive Akkermansia, MitoSober PQQ, QinMito L-Ergothioneine. B2B supplier model to supplement and cosmetic manufacturers.
  2. Cosmeceutical Ingredient Sales: Sale of bioactive ingredients for topical cosmetic applications including Fisetin Cosmetic, Urolithin A Cosmetic, L-Ergothionine Cosmetic.
  3. ODM Services: End-to-end formulation and manufacturing support including competitor analysis, consumer research, formula development, sampling, testing, optimization, and commercial-scale production.
  4. CDMO Services: Contract development and manufacturing services for patented active ingredients, exclusive formulations, novel delivery systems, and clinical trial expertise.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Bonerge Lifescience product offering

Product offering

Core offering

Bonerge Lifescience is a B2B ingredient manufacturer that develops, produces, and supplies nutraceutical and cosmeceutical raw materials to dietary supplement and personal care brands. The portfolio spans branded, clinically-supported longevity actives (such as fisetin, urolithin A, S-equol, L-ergothioneine, and PQQ) plus classic polyphenolic ingredients (apigenin, luteolin, resveratrol, polydatin, mangiferin, spermidine), delivered through proprietary bioavailability platforms. The company also offers ODM and CDMO services for finished dietary supplement products, including custom formulation, softgel encapsulation, and full turnkey brand support.

Product overview

Bonerge Lifescience is an innovative manufacturer providing comprehensive turn-key solutions in the nutraceutical and cosmeceutical ingredients industries. The company operates a multi-tiered product portfolio consisting of: (1) Branded Ingredients including EquoYouth™ S-Equol, StanYouth® Urolithin A, BeFisetin® Fisetin, Dihydroberberine (GlucoSober™), Amuctive™ Akkermansia, MitoSober® PQQ, and QinMito® L-Ergothioneine; (2) Cosmeceutical Ingredients for beauty-from-within applications; (3) Classic Ingredients including Apigenin, Luteolin, Genistein, Polydatin, Resveratrol, Mangiferin, and Spermidine; (4) Synergistic Formulations such as StanYouth® CR3; (5) ODM & CDMO manufacturing services; and (6) Proprietary Technology Platforms (Oil Soluble, Water Soluble, High-Bioavailability Softgel) that enhance bioavailability of active ingredients. The company focuses on ingredients for Ageless Energy, Healthspan, and Longevity.

Differentiator

Problem solved

Functional benefit

Brands

  • BeFisetin®: Premium branded fisetin ingredient - the first and only SA-GRAS certified fisetin with >99% purity.
  • EquoYouth™
  • StanYouth®
  • Amuctive™
  • Dihydroberberine
  • MitoSober®
  • QinMito®
  • GlucoSober™

Products and services

  • EquoYouth™ S-Equol

Quantifiable outcome

  • 54x higher bioavailability compared to berberine for dihydroberberine
  • +4 more outcomes

Companies that use Bonerge Lifescience

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Bonerge Lifescience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Bonerge Lifescience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NUS Centre for Healthy LongevitymajorStrategic or Co-development Partner · 1 January 2024Conference sponsor and participant at CHL Scientific Conference focused on healthy longevity supplements. Engaged with leading longevity researchers including Dr. Brian Kennedy, Dr. David Sinclair, Dr. Guido Kroemer, and Dr. Laura Niedernhofer to explore senolytic mechanisms and mitophagy research.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Bonerge Lifescience competitors and assessment

Company assessment

Direct peers

  • AIDP: US-based specialty ingredient supplier focused on branded, science-backed nutraceutical ingredients for healthy aging, cognitive, and metabolic health. Highly comparable mid-size competitor in Bonerge's target categories with established North American distribution.
  • Amazentis / Timeline Nutrition: Pioneer of branded, clinically-validated urolithin A ingredient (Mitopure) targeting mitochondrial health and longevity. Directly overlaps Bonerge's StanYouth® Urolithin A in active ingredient, indication (longevity), and B2B ingredient-supply model.
  • Sabinsa: Globally recognized manufacturer of standardized nutraceutical ingredients (curcuminoids, bioactives) with branded SKUs, clinical backing, and a global B2B sales network. Closely comparable to Bonerge's model of branded, clinically-supported nutraceutical ingredients sold to supplement brands.
  • Maypro Ingredients: Specialty nutraceutical ingredient distributor sourcing and marketing branded ingredients (many from Asia) to US supplement brands. Comparable business model to Bonerge's B2B branded-ingredient sales, particularly for the women's health and longevity categories.
  • ChromaDex: Public ingredient company behind Niagen® (nicotinamide riboside) and Tru Niagen, with strong IP and clinical evidence in the NAD+/longevity category. Highly comparable as a science-driven, branded-ingredient supplier in the longevity supplement market.
  • Sami Labs: Vertically integrated nutraceutical ingredient manufacturer with branded ingredients (e.g., BioPerine, Saberry) sold globally to supplement brands. Comparable B2B model with branded, clinically backed ingredients spanning metabolic, anti-aging, and women's health.

Broad incumbents

  • Kyowa Hakko Bio: Major Japanese fermentation-based ingredient manufacturer (e.g., Cognizin citicoline, branded amino acids) supplying global nutraceutical brands. Comparable as a fermentation-purity-focused, branded-ingredient supplier and a credible competitor in longevity and metabolic actives.
  • Lonza Capsules & Health Ingredients: Global CDMO and ingredient manufacturer offering delivery technologies (lipid multiparticulates, softgels) and bioavailability-enhanced ingredients to nutraceutical and pharma customers. Competes with Bonerge's delivery platforms and CDMO service lines at a much larger scale.

Emerging players

  • BioActor: Dutch developer and supplier of proprietary branded nutraceutical ingredients for metabolic, bone, and muscle health. Comparable as a smaller European science-driven ingredient supplier overlapping Bonerge's metabolic and women's health segments.
  • NuLivScience: Specialty ingredient company focused on branded, clinically-validated longevity and metabolic health actives (e.g., PeptiStrong). Similar size and positioning as Bonerge — emerging branded-ingredient supplier targeting the same healthspan supplement market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bonerge Lifescience social profiles

Digital presence

Bonerge Lifescience compliance and trust

Trust signal

Compliance3 records

Bonerge Lifescience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bonerge Lifescience leadership team

Management profile

Number of profiles

Profiles1 record

Bonerge Lifescience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bonerge Lifescience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bonerge Lifescience

What does Bonerge Lifescience do?

Bonerge Lifescience is a B2B ingredient manufacturer that develops, produces, and supplies nutraceutical and cosmeceutical raw materials to dietary supplement and personal care brands. The portfolio spans branded, clinically-supported longevity actives (such as fisetin, urolithin A, S-equol, L-ergothioneine, and PQQ) plus classic polyphenolic ingredients (apigenin, luteolin, resveratrol, polydatin, mangiferin, spermidine), delivered through proprietary bioavailability platforms. The company also offers ODM and CDMO services for finished dietary supplement products, including custom formulation, softgel encapsulation, and full turnkey brand support.

Is Bonerge Lifescience a public or private company?

Bonerge Lifescience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bonerge Lifescience founded?

Bonerge Lifescience was founded in 2022. It employs 11 to 50 people.

Where is Bonerge Lifescience based?

Bonerge Lifescience is headquartered in Changsha, China, in the Asia region.

How does Bonerge Lifescience make money?

Four revenue lines are on record. Branded Ingredient Sales are the primary driver. The others are cosmeceutical Ingredient Sales, ODM Services and CDMO Services.

Who are Bonerge Lifescience's main competitors?

Direct peers on record are AIDP, Amazentis / Timeline Nutrition, Sabinsa, Maypro Ingredients, ChromaDex and Sami Labs. Broad incumbents are Kyowa Hakko Bio and Lonza Capsules & Health Ingredients. Emerging players are BioActor and NuLivScience.

Does Bonerge Lifescience have an API?

No public API is recorded for Bonerge Lifescience.

What industry is Bonerge Lifescience in?

Bonerge Lifescience's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is CRADAGAM, Healthy Aging & Cognitive Support Supplements, with a secondary code of CRADAGAI, Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots). Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageBonerge Lifescience to Launch BonFusion™ and BonVesio™ Precision Delivery Platforms at SupplySide Global 2026Bonerge Lifescience announced BonFusion and BonVesio delivery platforms at SupplySide Global 2026, targeting urolithin A, fisetin, and S-equol. Preclinical data showed 3x higher bioavailability for water-dispersible urolithin A and >85% encapsulation efficiency for liposomal S-equol. The company invites partners to explore the platforms at Booth 7911-2.FinancialContent Business PageBonerge Launches Clinical Trial Investigating Circadian Recovery in Night Shift Healthcare WorkersBonerge has launched a randomized, double-blind, placebo-controlled clinical trial to investigate physiological and circadian recovery in anesthesiology residents following overnight hospital shifts. This study is part of the company's expanding clinical research program for its product StanYouth® Urolithin A, aiming to generate real-world evidence on how the body responds to circadian disruption.Business Wire BlogBonerge Launches Clinical Trial Investigating Circadian Recovery in Night Shift Healthcare WorkersBonerge has launched a randomized, double-blind, placebo-controlled clinical trial to investigate physiological recovery from circadian disruption in anesthesiology residents undergoing night shifts. This study is part of the company's expanding clinical research program for its ingredient StanYouth® Urolithin A, utilizing objective sleep monitoring and brain imaging to assess real-world recovery. The initiative aims to generate evidence on how biological systems respond to circadian stress in professional healthcare environments.MorningstarBonerge Lifescience Launches Clinical Study on EquoYouth® S-Equol for Menopause Symptom ReliefBonerge Lifescience announced an open-label clinical trial of its EquoYouth® S-equol ingredient for menopausal symptom relief. The 12-week, 10 mg daily regimen targets women aged 45–60 with moderate symptoms, measuring sleep, mood, and cognitive function. The company plans a randomized, double-blind, placebo-controlled trial after this exploratory study.Business Wire BlogBonerge Lifescience opened its new manufacturing facility to further support the innovation of its branded ingredientsBonerge Lifescience opened its new 70,000-square-meter manufacturing facility in Hunan, China, to produce plant extracts including its branded fisetin ingredient. The factory holds multiple quality certifications and includes a million-dollar analytical lab, supporting its second large-scale facility near raw material planting bases.